CLINICAL_TRIALS
trial_result
· 2021-08-03
Clinical Trial Update: ARTEMIS Peanut Allergy In Children [Phase 3]
Summary
Phase 3 trial update for ARTEMIS evaluating peanut allergy in children; study completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aimmune Therapeutics, Inc. | Conditions: Peanut Allergy | Phase 3 | Status: COMPLETED | Results posted: 2021-08-03